South Africa is known for its well-developed, highly liberalized financial sector. Particularly, the insurance industry of the country is the most developed in the entire African continent. As per our research report "South African Insurance Industry Forecast to 2013”, South Africa account for the bulk of the Africa’s total insurance business, i.e. a lion’s share of around 85%. In this way, it has left Tanzania and other 51 African countries with a collective share of merely 15%.
In the course of our research, we found that the South African insurance industry showed a remarkable resilience to the economic turmoil of 2008 that entangled most of the industries across the world. In fact, the long-term insurance sector of the country continued the trend of positive growth during this adverse time and registered about 11.5% growth rate during 2008. In future also, it is anticipated to maintain the healthy growth rate.
Most importantly, the policyholders not only maintained their premiums for life and disability insurance and fund policies in 2008, but they also continued to increase them. The life insurance industry managed to attract new individual recurring as well as single premiums of ZAR 65 Billion during 2008, an increase of 14% over 2007.
The report also highlights that with the increased demand of medical, motor and property insurance, short-term insurance industry is also set to rollout tremendously in the coming years. By net premium, short-term insurance industry is expected to grow at a CAGR of about 11% during 2009-2013. Growing demand for liability and engineering insurance will favor the future growth.
"South African Insurance Industry Forecast to 2013” provides extensive research and in-depth analysis of the insurance sector of South Africa. The report will help clients to evaluate the leading-edge opportunities critical to the success of the country’s insurance industry. It also provides future outlook on the key segments of the industry, besides shedding light on the key players in the industry (including both domestic as well as foreign players).
The forecast given in the report is not based on a complex economic model, but is intended as a rough guide to the direction in which the market is likely to move. This forecast is based on a correlation between past market growth and growth of base drivers.
For more please visit
http://www.bharatbook.com/detail.asp?id=104777&rt=South-African-Insurance-Industry-Forecast.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Thursday, December 30, 2010
Indian Non-Alcoholic Drinks Forecast to 2012
India has witnessed radical shift in consumption of non-alcoholic drinks over the recent past. Fast expanding middle class population that is currently around 350 Million, increased urbanization and rising disposable income are some of the major reasons contributing to this change. Besides this, growing health consciousness among India’s young population has brought about a revolution in the Indian non-alcoholic drinks market. It has been seen that cola sales have fallen dramatically due to rising health concerns and this seems to have benefited the country’s non-carbonated drinks market such as energy drinks and juices.
According to our recent report “Indian Non-Alcoholic Drinks Forecast to 2012”, the Indian non-alcoholic drinks market was estimated at around Rs. 216 Billion in 2008 and is forecasted to grow at a CAGR of around 15% during 2009-2012. The report covers various factors driving the growth of non-alcoholic drinks market in India.
The segment level analysis shows that the highest growth will be seen in the fruit/vegetable juice market, which is forecasted to growth at a CAGR of around 30% in value terms during 2009-2012. It will be closely followed by the energy drinks segment at a CAGR of around 29% during the same period. There is a greater awareness of the ‘functional’ benefits of health beverages and a greater willingness to pay a premium for such beverages. With these strong drivers of growth, it is not surprising that the beverage industry in India has begun responding with products that are marketed clearly on a health and wellness platform.
“Indian Non-Alcoholic Drinks Forecast to 2012” provides detailed study on the non-alcoholic drinks market in the country. For the purpose of this report, non-alcoholic drinks are classified into carbonated and non-carbonated drinks. These include energy drinks, fruit/vegetable drinks, bottled water, tea, coffee and carbonated drinks. Each of the segments has been thoroughly analyzed from the point of view of current market performance and the future outlook to 2012. Various factors supporting the future growth and expansion have been extensively covered in the report.
For more please visit
http://www.bharatbook.com/detail.asp?id=104755&rt=Indian-Non-Alcoholic-Drinks-Forecast.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
According to our recent report “Indian Non-Alcoholic Drinks Forecast to 2012”, the Indian non-alcoholic drinks market was estimated at around Rs. 216 Billion in 2008 and is forecasted to grow at a CAGR of around 15% during 2009-2012. The report covers various factors driving the growth of non-alcoholic drinks market in India.
The segment level analysis shows that the highest growth will be seen in the fruit/vegetable juice market, which is forecasted to growth at a CAGR of around 30% in value terms during 2009-2012. It will be closely followed by the energy drinks segment at a CAGR of around 29% during the same period. There is a greater awareness of the ‘functional’ benefits of health beverages and a greater willingness to pay a premium for such beverages. With these strong drivers of growth, it is not surprising that the beverage industry in India has begun responding with products that are marketed clearly on a health and wellness platform.
“Indian Non-Alcoholic Drinks Forecast to 2012” provides detailed study on the non-alcoholic drinks market in the country. For the purpose of this report, non-alcoholic drinks are classified into carbonated and non-carbonated drinks. These include energy drinks, fruit/vegetable drinks, bottled water, tea, coffee and carbonated drinks. Each of the segments has been thoroughly analyzed from the point of view of current market performance and the future outlook to 2012. Various factors supporting the future growth and expansion have been extensively covered in the report.
For more please visit
http://www.bharatbook.com/detail.asp?id=104755&rt=Indian-Non-Alcoholic-Drinks-Forecast.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Advanced Flat Glass to 2014
US demand to increase 7.7% annually through 2014
Demand for advanced flat glass products is projected to increase 7.7 percent annually from a weak 2009 base to 723 million square feet in 2014, valued at $6.8 billion. Gains will derive from the recovery of the US economy from the recession, which will spark a rebound in new housing construction and motor vehicle production. Both of these key markets for advanced flat glass contracted sharply from 2007 through 2009, reflecting turmoil in financial markets, the restructuring of the US auto industry and the collapse of the housing market. As the economy in general and the housing and motor vehicle markets in particular recover from these events, demand for advanced flat glass products will benefit.
Safety, security glass to remain dominant segment
Safety and security glass will continue to dominate overall demand in both volume and value terms, with the majority of demand utilized in vehicular markets. Consumption will benefit from rebounding motor vehicle production and the increasing replacement of traditional tempered glass with laminated glass, particularly in sun roofs and side lites. In architectural markets, demand will benefit from strong growth in new housing construction, coupled with expanding use of laminated glass products such as hurricane glass, ballistic glass and burglary resistant glass.
Solar control glass to be fastest growing products
Solar control glass will post the most rapid value gains through 2014, with demand benefiting from growth in new housing construction and expanding use of products designed to improve energy efficiency, such as low-emissivity glassand smart glass products. Supported by government incentives and the promise of lower heating and cooling costs, products such as low-e glass are becoming the standard in insulated window units for both the new construction and replacement markets. Smart glass products, while still largely in the development stage, will post outsized growth as these products begin to enter the market. In vehicular markets, demand will benefit from the increasing use of electrochromic mirrors, which continue to become more advanced multi-purpose display features on a growing number of motor vehicle models.
Heads-up display windshields to pace other types
Other advanced flat glass products include well established products such as ultraclear glass and glass used in furniture and appliance markets, as well as new products, such as self-cleaning glass and heads-up display winshields. The latter will continue to have the greater growth opportunities, albeit from relatively small bases, as these technologies gain acceptance. Heads-up displays will benefit from the increasing sophistication and electronics content of motor vehicle cabins, offering drivers more information and improving vehicle safety. Self-cleaning glass will increase its penetration of architectural markets as more builders and home-owners come to accept the advantages of the technology.
Study coverage
This new Freedonia industry study, Advanced Flat Glass, is priced at $4800. It presents historical demand data (1999, 2004 and 2009) plus forecasts for 2014 and 2019 by product (e.g., safety and security glass, solar control glass) and market (e.g., vehicular, architectural). The study also considers market environment factors, evaluates company market share and profiles industry competitors, including AFG Industries (Asahi Glass), Cardinal Glass, Guardian Industries, PPG Industries and Pilkington.
For more please visit
http://www.bharatbook.com/detail.asp?id=167180&rt=Advanced-Flat-Glass-to-2014.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Demand for advanced flat glass products is projected to increase 7.7 percent annually from a weak 2009 base to 723 million square feet in 2014, valued at $6.8 billion. Gains will derive from the recovery of the US economy from the recession, which will spark a rebound in new housing construction and motor vehicle production. Both of these key markets for advanced flat glass contracted sharply from 2007 through 2009, reflecting turmoil in financial markets, the restructuring of the US auto industry and the collapse of the housing market. As the economy in general and the housing and motor vehicle markets in particular recover from these events, demand for advanced flat glass products will benefit.
Safety, security glass to remain dominant segment
Safety and security glass will continue to dominate overall demand in both volume and value terms, with the majority of demand utilized in vehicular markets. Consumption will benefit from rebounding motor vehicle production and the increasing replacement of traditional tempered glass with laminated glass, particularly in sun roofs and side lites. In architectural markets, demand will benefit from strong growth in new housing construction, coupled with expanding use of laminated glass products such as hurricane glass, ballistic glass and burglary resistant glass.
Solar control glass to be fastest growing products
Solar control glass will post the most rapid value gains through 2014, with demand benefiting from growth in new housing construction and expanding use of products designed to improve energy efficiency, such as low-emissivity glassand smart glass products. Supported by government incentives and the promise of lower heating and cooling costs, products such as low-e glass are becoming the standard in insulated window units for both the new construction and replacement markets. Smart glass products, while still largely in the development stage, will post outsized growth as these products begin to enter the market. In vehicular markets, demand will benefit from the increasing use of electrochromic mirrors, which continue to become more advanced multi-purpose display features on a growing number of motor vehicle models.
Heads-up display windshields to pace other types
Other advanced flat glass products include well established products such as ultraclear glass and glass used in furniture and appliance markets, as well as new products, such as self-cleaning glass and heads-up display winshields. The latter will continue to have the greater growth opportunities, albeit from relatively small bases, as these technologies gain acceptance. Heads-up displays will benefit from the increasing sophistication and electronics content of motor vehicle cabins, offering drivers more information and improving vehicle safety. Self-cleaning glass will increase its penetration of architectural markets as more builders and home-owners come to accept the advantages of the technology.
Study coverage
This new Freedonia industry study, Advanced Flat Glass, is priced at $4800. It presents historical demand data (1999, 2004 and 2009) plus forecasts for 2014 and 2019 by product (e.g., safety and security glass, solar control glass) and market (e.g., vehicular, architectural). The study also considers market environment factors, evaluates company market share and profiles industry competitors, including AFG Industries (Asahi Glass), Cardinal Glass, Guardian Industries, PPG Industries and Pilkington.
For more please visit
http://www.bharatbook.com/detail.asp?id=167180&rt=Advanced-Flat-Glass-to-2014.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Cosmetic Surgery Products to 2014
Demand for products used in cosmetic surgery is forecast to increase 6.5 percent per year to $2.8 billion in 2014, when 16.1 million cosmetic procedures are expected to be performed. The economic recession that began in December 2007 impacted the cosmetic surgery industry most profoundly in surgical procedures, which suffered large drops in 2008 and 2009. Likewise, demand for equipment used to perform these surgeries fell more sharply than did that for less expensive, non-invasive nonsurgical procedures. Busy lifestyles and pervasive unemployment rates have led to rapid increases in demand for minimally invasive procedures (such as injections and laser-based procedures). Minimally or non-invasive procedures will continue to take market share from invasive surgeries, although healthy growth will remain in some areas, such as implants, where there are no notable alternatives.
Lasers, other light-based equipment to remain largest, fastest-growing
Equipment has traditionally held the largest share of the cosmetic surgery product market, and in 2009 accounted for over one-third of demand. Purchases of equipment were slowed by the recession and should see a strong rebound. Lasers and other light-based systems will continue to be the largest sector of equipment demand, and will see the fastest growth going forward as new laser-based treatments such as noninvasive liposuction enter the market.
Injectables and implants fastest-growing products
Through 2014, injectables and implants will continue to be the two fastestgrowing product segments. Growth in demand for injectables has boomed since the 1990s when BOTOX (Allergan) first entered the market. Cosmetic injections benefit from increasing societal acceptance as well as high consumer awareness of their ability to provide a quick, noninvasive reduction in wrinkles with no recovery time. With 2009 and 2010 market approvals of competing botulinum toxin-based injectables, BOTOX is seeing its first direct competition, which is expected to have significant impact on the market. Development of newergeneration soft tissue fillers will also continue, with this segment expected to see the fastest gains among injectables. Implants will continue to benefit from silicone’s market re-entry in 2006, as breast implants -- the most common aesthetic surgical procedure -- remain fast-growing. Next-generation implant materials (so-called “gummy bear” implants) are forecast to enter the market once they receive FDA approval following clinical testing. These higher-value implants will drive further value gains.
Study coverage
Cosmetic Surgery Products is a new Freedonia industry study available for $4800. It presents historical demand data (1999, 2004 and 2009) plus forecasts for 2014 and 2019 by procedure, product and raw material. The study also assesses key market environment factors, evaluates company market share and profiles 29 US industry competitors
For more please visit
http://www.bharatbook.com/detail.asp?id=167181&rt=Cosmetic-Surgery-Products-to-2014.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Lasers, other light-based equipment to remain largest, fastest-growing
Equipment has traditionally held the largest share of the cosmetic surgery product market, and in 2009 accounted for over one-third of demand. Purchases of equipment were slowed by the recession and should see a strong rebound. Lasers and other light-based systems will continue to be the largest sector of equipment demand, and will see the fastest growth going forward as new laser-based treatments such as noninvasive liposuction enter the market.
Injectables and implants fastest-growing products
Through 2014, injectables and implants will continue to be the two fastestgrowing product segments. Growth in demand for injectables has boomed since the 1990s when BOTOX (Allergan) first entered the market. Cosmetic injections benefit from increasing societal acceptance as well as high consumer awareness of their ability to provide a quick, noninvasive reduction in wrinkles with no recovery time. With 2009 and 2010 market approvals of competing botulinum toxin-based injectables, BOTOX is seeing its first direct competition, which is expected to have significant impact on the market. Development of newergeneration soft tissue fillers will also continue, with this segment expected to see the fastest gains among injectables. Implants will continue to benefit from silicone’s market re-entry in 2006, as breast implants -- the most common aesthetic surgical procedure -- remain fast-growing. Next-generation implant materials (so-called “gummy bear” implants) are forecast to enter the market once they receive FDA approval following clinical testing. These higher-value implants will drive further value gains.
Study coverage
Cosmetic Surgery Products is a new Freedonia industry study available for $4800. It presents historical demand data (1999, 2004 and 2009) plus forecasts for 2014 and 2019 by procedure, product and raw material. The study also assesses key market environment factors, evaluates company market share and profiles 29 US industry competitors
For more please visit
http://www.bharatbook.com/detail.asp?id=167181&rt=Cosmetic-Surgery-Products-to-2014.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Flash Memory Market to 2020 - Heading Towards a Solid Recovery Driven by Sales Growth of Tablet PCs, Smart Phones and Digital Cameras
“Flash Memory Market to 2020 - Heading Towards a Solid Recovery Driven by Sales Growth of Tablet PCs, Smart Phones and Digital Cameras” analyzes the Global Flash memory Industry. Flash memory is a non-volatile computer storage technology primarily used in memory cards, USB flash drives, and solid-state drives for general storage.
Scope
- Key countries such as China, Taiwan and South Korea covered for the report
- Thorough Qualitative analysis of the market - PESTLE Analysis, Market Drivers, restraints, Porter's Five Forces Model
- Annualized sale volume and sales revenue data of key semiconductor devices from 2004 to 2009
- Annualized sale volume and sales revenue data forecast forward to 11 years to 2020
- Market share data of key market segments for the base year 2009
- Comprehensive Supply Chain analysis
- Comprehensive Profiles of Key Players
Reasons to buy
- Develop business strategies from the market size and growth data given for global Flash memory market
- Understand the competitors operating in the Flash memory market
- Devise revenue growth strategy from the market share data
- Devise product, sales and marketing strategies from the PESTLE And Porter's Five Forces Analyses
- Identify key growth markets for your products from the country-wise market statistics
Companies Mentioned
Samsung Electronics Co., Ltd
Intel Corporation
Hynix Semiconductor Inc.
Micron Technology, Inc.
Spansion Inc.
Toshiba America Electronic Components, Inc.
For more please visit
http://www.bharatbook.com/detail.asp?id=167046&rt=Flash-Memory-Market-to-2020-Heading-Towards-a-Solid-Recovery-Driven-by-Sales-Growth-of-Tablet-PCs-Smart-Phones-and-Digital-Cameras.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Scope
- Key countries such as China, Taiwan and South Korea covered for the report
- Thorough Qualitative analysis of the market - PESTLE Analysis, Market Drivers, restraints, Porter's Five Forces Model
- Annualized sale volume and sales revenue data of key semiconductor devices from 2004 to 2009
- Annualized sale volume and sales revenue data forecast forward to 11 years to 2020
- Market share data of key market segments for the base year 2009
- Comprehensive Supply Chain analysis
- Comprehensive Profiles of Key Players
Reasons to buy
- Develop business strategies from the market size and growth data given for global Flash memory market
- Understand the competitors operating in the Flash memory market
- Devise revenue growth strategy from the market share data
- Devise product, sales and marketing strategies from the PESTLE And Porter's Five Forces Analyses
- Identify key growth markets for your products from the country-wise market statistics
Companies Mentioned
Samsung Electronics Co., Ltd
Intel Corporation
Hynix Semiconductor Inc.
Micron Technology, Inc.
Spansion Inc.
Toshiba America Electronic Components, Inc.
For more please visit
http://www.bharatbook.com/detail.asp?id=167046&rt=Flash-Memory-Market-to-2020-Heading-Towards-a-Solid-Recovery-Driven-by-Sales-Growth-of-Tablet-PCs-Smart-Phones-and-Digital-Cameras.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets
“Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various patent protection strategies adopted by pharmaceutical companies for maximizing revenues returns from the branded drugs. The report analyzes the effective patent strategies and provides you a multi-strategy approach to defend your products from generics. It gives you a robust idea on successful patent portfolio management. Furthermore, the report analyzes the patent strategies that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
The scope of this report includes:
- Understanding of the R&D process and the necessity of patent protection.
- An overview of current patent protection mechanisms employed by pharmaceutical companies.
- Detailed study of pre-patent protection strategies with special emphasis on strategies which help combating generic competition.
- Post-patent expiry strategies like authorized generics and orange book delisting with case studies.
- Inputs for customized patent strategy based on business situation.
- Case studies of successful patent strategies.
Reasons to buy
The report will enhance your decision making capability. It will provide you with:
- Build understanding of the key Patent strategies in place and the trends in the market
- Optimize your R&D pipeline through identification and understanding of the key strategy for your drug.
- Identify the key players best positioned to capitalize on their products through effective management of the lifecycle of their patented products.
- Develop effective business strategies related to Patents through the analytical insight gained from case studies covering different strategies in the market.
- Understand the fit between the patent strategy and your product considering various factors pertaining to the market, product and therapeutic area.
- Ensure success in patent portfolio management through the analysis of key success and failure factors and the use of the framework for measuring performance.
For more please visit
http://www.bharatbook.com/detail.asp?id=167045&rt=Patent-Strategies-Effective-Strategies-for-Extension-of-Product-Lifecycles-and-Combating-Aggressive-Generics-Markets.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Scope
The scope of this report includes:
- Understanding of the R&D process and the necessity of patent protection.
- An overview of current patent protection mechanisms employed by pharmaceutical companies.
- Detailed study of pre-patent protection strategies with special emphasis on strategies which help combating generic competition.
- Post-patent expiry strategies like authorized generics and orange book delisting with case studies.
- Inputs for customized patent strategy based on business situation.
- Case studies of successful patent strategies.
Reasons to buy
The report will enhance your decision making capability. It will provide you with:
- Build understanding of the key Patent strategies in place and the trends in the market
- Optimize your R&D pipeline through identification and understanding of the key strategy for your drug.
- Identify the key players best positioned to capitalize on their products through effective management of the lifecycle of their patented products.
- Develop effective business strategies related to Patents through the analytical insight gained from case studies covering different strategies in the market.
- Understand the fit between the patent strategy and your product considering various factors pertaining to the market, product and therapeutic area.
- Ensure success in patent portfolio management through the analysis of key success and failure factors and the use of the framework for measuring performance.
For more please visit
http://www.bharatbook.com/detail.asp?id=167045&rt=Patent-Strategies-Effective-Strategies-for-Extension-of-Product-Lifecycles-and-Combating-Aggressive-Generics-Markets.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Wednesday, December 29, 2010
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
The leading business intelligence provider, has released its latest research, “Oncology Market in India to 2017 – Limited Patient Affordability for High Priced Biologics Lowers Market Potential”, which provides insights into oncology sales and price forecasts until 2017. The report also examines the Indian oncology treatment usage patterns. In addition, the report also includes insights into the oncology R&D pipeline. The report provides an in-depth analysis of the top five oncology therapeutic indications, which are breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s Lymphoma (NHL).
Scope
The report covers:
- Data and analysis on the oncology market in India.
- Annualized market data for the oncology market from 2002 to 2009, with forecasts to 2017.
- Market data on the therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.
- Key drivers and restraints that have had a significant impact on the market and on each indication.
- The competitive landscape of the oncology market includes both Indian players and foreign players.
- Key M&A activities and Licensing Agreements that took place from 2004 to 2010 in the Indian oncology market.
Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to:
- Build effective strategies to launch their pipeline products by identifying potential of the market.
- Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Develop market-entry and market expansion strategies by identifying each indication’s growth rate.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.
Companies Mentioned
Dr. Reddy’s Lab
Piramal Healthcare
Biocon Limited
Cipla Ltd.
Sanofi-Aventis
F. Hoffmann-La Roche Ltd/Genentech, Inc.
AstraZeneca
GlaxoSmithKline
For more please visit
http://www.bharatbook.com/detail.asp?id=167044&rt=Oncology-Market-in-India-to-2017-Limited-Patient-Affordability-for-High-Priced-Biologics-Lowers-Market-Potential.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Scope
The report covers:
- Data and analysis on the oncology market in India.
- Annualized market data for the oncology market from 2002 to 2009, with forecasts to 2017.
- Market data on the therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.
- Key drivers and restraints that have had a significant impact on the market and on each indication.
- The competitive landscape of the oncology market includes both Indian players and foreign players.
- Key M&A activities and Licensing Agreements that took place from 2004 to 2010 in the Indian oncology market.
Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to:
- Build effective strategies to launch their pipeline products by identifying potential of the market.
- Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Develop market-entry and market expansion strategies by identifying each indication’s growth rate.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.
Companies Mentioned
Dr. Reddy’s Lab
Piramal Healthcare
Biocon Limited
Cipla Ltd.
Sanofi-Aventis
F. Hoffmann-La Roche Ltd/Genentech, Inc.
AstraZeneca
GlaxoSmithKline
For more please visit
http://www.bharatbook.com/detail.asp?id=167044&rt=Oncology-Market-in-India-to-2017-Limited-Patient-Affordability-for-High-Priced-Biologics-Lowers-Market-Potential.html
OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Subscribe to:
Posts (Atom)